Literature DB >> 4226104

Retroperitoneal fibrosis secondary to methysergide bimaleate.

N C Kerbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4226104      PMCID： PMC1922966     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  RETROPERITONEAL FIBROSIS IN PATIENTS TAKING METHYSERGIDE.

Authors:  D C UTZ; E D ROOKE; J A SPITTELL; L G BARTHOLOMEW
Journal:  JAMA       Date:  1965-03-22       Impact factor: 56.272

2.  RETROPERITONEAL FIBROSIS: A MISSING LINK IN THE CHAIN.

Authors:  H I SUBY; W S KERR; J R GRAHAM; E FRALEY
Journal:  J Urol       Date:  1965-02       Impact factor: 7.450

3.  Reversible retroperitoneal fibrosis with ureteral obstruction associated with ingestion of sansert.

Authors:  J M Weiss; F Hinman
Journal:  J Urol       Date:  1966-06       Impact factor: 7.450

4.  Fibrotic disorders associated with methysergide therapy for headache.

Authors:  J R Graham; H I Suby; P R LeCompte; N L Sadowsky
Journal:  N Engl J Med       Date:  1966-02-17       Impact factor: 91.245

5.  Idiopathic retroperitoneal fibrosis: Ormond's syndrome.

Authors:  J K ORMOND
Journal:  Henry Ford Hosp Med Bull       Date:  1962-03
  5 in total
  2 in total

1.  Retroperitoneal fibrosis.

Authors:  S C Thorson
Journal:  Can Med Assoc J       Date:  1973-04-21       Impact factor: 8.262

2.  Mitral regurgitation occurring during methsergide (Sansert) therapy.

Authors:  D S Munroe; P Allen; A R Cox
Journal:  Can Med Assoc J       Date:  1969-11-01       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.